Navigation Links
Caliper Life Sciences' Fourth Quarter 2007 Financial Results Conference Call Notice
Date:2/19/2008

TUESDAY, February 26, 2008 9:00 a.m. EST

HOPKINTON, Mass., Feb. 19 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) will conduct a conference call discussing the company's fourth quarter 2007 financial results at 9:00 a.m. EST on Tuesday, February 26. Kevin Hrusovsky, President and Chief Executive Officer and Tom Higgins, Chief Financial Officer, will host the call. Management will discuss operational and financial results and the company's outlook for the future.

A news release discussing Caliper's fourth quarter 2007 financial results will be issued Tuesday, February 26 at approximately 7:00 a.m. EST.

Participants, please call 888-713-4215 five to ten minutes prior to the call and use the participant passcode of 54563865. International callers can access the call by dialing 617-213-4867 and entering the same passcode. You may also pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=PKKMX3XKF.

A live webcast of the call can be accessed at http://www.fulldisclosure.com or on the Caliper website at http://www.caliperLS.com in the Events section of the Investor Relations page. A webcast replay of the call will remain available until Caliper's earnings call for the first quarter of 2008.

Telephone replays of the conference call will be available approximately two hours after the completion of the call. To access a telephone playback of the proceedings from February 26 through March 4, dial 888-286-8010 and use the participant passcode of 19800700. International callers can access the playback by dialing 617-801-6888 and using the same participant passcode.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Caliper Life Sciences to Present at Deutsche Bank 2008 Small and Mid Cap Growth Conference
2. Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference Today
3. Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference
4. Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction
5. Caliper Life Sciences to Participate in Deutsche Banks Healthcare Technology Industry Day
6. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
7. Caliper Life Sciences Presentation at UBS Global Life Sciences Conference to be Webcast
8. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
9. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
10. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
11. Advanced Life Sciences Announces Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... , Feb. 28, 2017  ITL Limited ... company, supplier and strategic partner that provides innovative ... individual health management, formally announces its rebrand to ... name change is part of the Company,s unified ... launch of an integrated corporate website, ITLHealthGroup.com ...
(Date:2/28/2017)... -- The Biotech industry is today,s focus on ... ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ), Aurinia Pharmaceuticals ... ARNA ), and Marinus Pharmaceuticals Inc. (NASDAQ: ... which was narrowly mixed on Monday, February 27 th , ... 0.1%, while shares of health care companies in the S&P ...
(Date:2/27/2017)... , Feb. 27, 2017 AcelRx Pharmaceuticals, ... on the development and commercialization of innovative therapies ... today the U.S. Food and Drug Administration (FDA) ... under section 505(b)(2) for DSUVIA™ (formerly ARX-04) (sufentanil ... patients with moderate-to-severe acute pain in a medically ...
(Date:2/27/2017)... ... February 27, 2017 , ... In starting a program to hire college athletes, ... for attitude. Train for skill.” , In keeping with this philosophy, the Catalyst an ... salesman. Zamzow is hoping to replicate the practice throughout the company. , “I’ve heard ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 The biometrics ... by the confluence of organizations, desires to better ... knowledge-based systems (password and challenge questions), biometrics is ... government systems. The market is driven by use ... between consumer and enterprise uses cases, with consumer-facing ...
(Date:2/7/2017)... Minn. , Feb. 7, 2017   MedNet ... supports the entire spectrum of clinical research, is pleased ... iMedNet , its innovative, highly flexible and award ... iMedNet customers. iMedNet is a proven ... provides Electronic Data Capture (EDC), but also delivers an ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
Breaking Biology News(10 mins):